Validity of the Handheld Expiratory Flowmeter for COPD Screening in the Primary Care Setting of China

References

• Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. doi:10.1371/journal.pmed.0030442
   PubMed Web of Science ®Google Scholar
• World Health Organisation. The Global Burden of Disease: 2004 Update. 2008.
   Google Scholar
• Soriano JB, Abajobir AA, Abate KH; Collaborators GBDCRD. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691–706. doi:10.1016/S2213-2600(17)30293-X
   PubMed Web of Science ®Google Scholar
• Lange P, Halpin DM, O’Donnell DE, MacNee W. Diagnosis, assessment, and phenotyping of COPD: beyond FEV(1). Int J Chron Obstruct Pulmon Dis. 2016;11:3–12. doi:10.2147/COPD.S85976
   PubMedGoogle Scholar
• Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019.
   Web of Science ®Google Scholar
• Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932–946. doi:10.1183/09031936.04.00014304
   PubMed Web of Science ®Google Scholar
• Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet. 2009;374(9691):721–732. doi:10.1016/S0140-6736(09)61290-3
   PubMed Web of Science ®Google Scholar
• Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax. 2008;63(5):402–407. doi:10.1136/thx.2007.085456
   PubMed Web of Science ®Google Scholar
• Freeman D, Price D. ABC of chronic obstructive pulmonary disease. Primary care and palliative care. BMJ. 2006;333(7560):188–190. doi:10.1136/bmj.333.7560.188
   PubMedGoogle Scholar
• Labonté LE, Tan WC, Li PZ, et al. Undiagnosed chronic obstructive pulmonary disease contributes to the burden of health care use. Data from the CanCOLD Study. Am J Respir Crit Care Med. 2016;194(3):285–298. doi:10.1164/rccm.201509-1795OC
   PubMed Web of Science ®Google Scholar
• Han MK, Kim MG, Mardon R, et al. Spirometry utilization for COPD: how do we measure up? Chest. 2007;132(2):403–409. doi:10.1378/chest.06-2846
   PubMed Web of Science ®Google Scholar
• Johns DP, Burton D, Walters JA, Wood-Baker R. National survey of spirometer ownership and usage in general practice in Australia. Respirology. 2006;11(3):292–298. doi:10.1111/j.1440-1843.2006.00851.x
   PubMed Web of Science ®Google Scholar
• Leuppi JD, Miedinger D, Chhajed PN, et al. Quality of spirometry in primary care for case finding of airway obstruction in smokers. Respiration. 2010;79(6):469–474. doi:10.1159/000243162
   PubMed Web of Science ®Google Scholar
• Derom E, van Weel C, Liistro G, et al. Primary care spirometry. Eur Respir J. 2008;31(1):197–203. doi:10.1183/09031936.00066607
   PubMed Web of Science ®Google Scholar
• Qaseem A, Snow V, Shekelle P, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2007;147(9):633–638. doi:10.7326/0003-4819-147-9-200711060-00008
   PubMed Web of Science ®Google Scholar
• Calonge N, Petitti DB, DeWitt TG, et al. Screening for chronic obstructive pulmonary disease using spirometry: U.S. preventive services task force recommendation statement. Ann Intern Med. 2008;148(7):529–534. doi:10.7326/0003-4819-148-7-200804010-00212
   PubMed Web of Science ®Google Scholar
• Prats E, Tejero E, Pardo P, et al. Prognostic value of the six-second spirometry in patients with chronic obstructive pulmonary disease: a Cohort Study. PLoS One. 2015;10(10):e0140855. doi:10.1371/journal.pone.0140855
   PubMed Web of Science ®Google Scholar
• Chung KS, Jung JY, Park MS, et al. Cut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean population. Int J Chron Obstruct Pulmon Dis. 2016;11:1957–1963. doi:10.2147/COPD.S113568
   PubMed Web of Science ®Google Scholar
• Lundgren FL, Cabral MM, Climaco DC, de Macedo LG, Coelho MA, Dias AL. Determination of the efficacy of FEV6 as a surrogate for FVC in the diagnostic screening for chronic obstructive pulmonary disease through the comparison of FEV1/FVC and FEV1/FEV6 ratios. J Bras Pneumol. 2007;33(2):148–151. doi:10.1590/S1806-37132007000200008
   PubMedGoogle Scholar
• Vandevoorde J, Verbanck S, Schuermans D, Kartounian J, Vincken W. FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction. Chest. 2005;127(5):1560–1564. doi:10.1378/chest.127.5.1560
   PubMed Web of Science ®Google Scholar
• Vollmer WM, Gislason T, Burney P, et al. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD Study. Eur Respir J. 2009;34(3):588–597. doi:10.1183/09031936.00164608
   PubMed Web of Science ®Google Scholar
• Jing JY, Huang TC, Cui W, Xu F, Shen HH. Should FEV1/FEV6 replace FEV1/FVC ratio to detect airway obstruction? A metaanalysis. Chest. 2009;135(4):991–998. doi:10.1378/chest.08-0723
   PubMed Web of Science ®Google Scholar
• Frith P, Crockett A, Beilby J, et al. Simplified COPD screening: validation of the PiKo-6(R) in primary care. Prim Care Respir J. 2011;20(2):190–198, 192. doi:10.4104/pcrj.2011.00040
   PubMedGoogle Scholar
• Sichletidis L, Spyratos D, Papaioannou M, et al. A combination of the IPAG questionnaire and PiKo-6(R) flow meter is a valuable screening tool for COPD in the primary care setting. Prim Care Respir J. 2011;20(2):184–189, 181. doi:10.4104/pcrj.2011.00038
   PubMedGoogle Scholar
• Wada H, Nakano Y, Nagao T, et al. Detection and prevalence of chronic obstructive pulmonary disease in a cardiovascular clinic: evaluation using a hand held FEV/FEV meter and questionnaire. Respirology. 2010;15(8):1252–1258. doi:10.1111/j.1440-1843.2010.01854.x
   PubMed Web of Science ®Google Scholar
• Represas RC, Botana RM, Leiro FV, Gonzalez SA, Del CPV, Fernandez-Villar A. [Assessment of the portable COPD-6 device for detecting obstructive airway diseases]. Arch Bronconeumol. 2010;46(8):426–432. Spanish. doi:10.1016/S1579-2129(10)70101-4
   PubMed Web of Science ®Google Scholar
• Thorn J, Tilling B, Lisspers K, Jorgensen L, Stenling A, Stratelis G. Improved prediction of COPD in at-risk patients using lung function pre-screening in primary care: a real-life study and cost-effectiveness analysis. Prim Care Respir J. 2012;21(2):159–166. doi:10.4104/pcrj.2011.00104
   PubMedGoogle Scholar
• Miravitlles M, Llor C, Calvo E, Diaz S, Diaz-Cuervo H, Gonzalez-Rojas N. [Validation of the Spanish version of the chronic obstructive pulmonary disease-population screener (COPD-PS). Its usefulness and that of FEV(1)/FEV(6) for the diagnosis of COPD]. Med Clin (Barc). 2011;139(12):522–530. Italian. doi:10.1016/j.medcli.2011.06.022
   PubMed Web of Science ®Google Scholar
• Nishimura K, Nakayasu K, Kobayashi A, Mitsuma S. Case identification of subjects with airflow limitations using the handheld spirometer “Hi-Checker”: comparison against an electronic desktop spirometer. COPD. 2011;8(6):450–455. doi:10.3109/15412555.2011.626817
   PubMedGoogle Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
   PubMed Web of Science ®Google Scholar
• Enright PL, Studnicka M, Zielinski J. Spirometry to detect and manage chronic obstructive pulmonary disease and asthma in the primary care setting. Eur Respir Monogr. 2005:1–14.
   Google Scholar
• Toda R, Hoshino T, Kawayama T, et al. Validation of “lung age” measured by spirometry and handy electronic FEV1/FEV6 meter in pulmonary diseases. Intern Med. 2009;48(7):513–521. doi:10.2169/internalmedicine.48.1781
   PubMed Web of Science ®Google Scholar
• Vandevoorde J, Verbanck S, Schuermans D, Kartounian J, Vincken W. Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/FEV6 and FEV6. Eur Respir J. 2006;27(2):378–383. doi:10.1183/09031936.06.00036005
   PubMed Web of Science ®Google Scholar
• Melbye H, Medbo A, Crockett A. The FEV1/FEV6 ratio is a good substitute for the FEV1/FVC ratio in the elderly. Prim Care Respir J. 2006;15(5):294–298. doi:10.1016/j.pcrj.2006.07.002
   PubMedGoogle Scholar
• Rosa FW, Perez-Padilla R, Camelier A, Nascimento OA, Menezes AM, Jardim JR. Efficacy of the FEV1/FEV6 ratio compared to the FEV1/FVC ratio for the diagnosis of airway obstruction in subjects aged 40 years or over. Braz J Med Biol Res. 2007;40(12):1615–1621. doi:10.1590/S0100-879X2006005000182
   PubMed Web of Science ®Google Scholar
• Dickens AP, Fitzmaurice DA, Adab P, et al. Accuracy of Vitalograph lung monitor as a screening test for COPD in primary care. NPJ Prim Care Respir Med. 2020;30(1). doi:10.1038/s41533-019-0158-2
   PubMed Web of Science ®Google Scholar
• Lamprecht B, Schirnhofer L, Tiefenbacher F, et al. Six-second spirometry for detection of airway obstruction: a population-based study in Austria. Am J Respir Crit Care Med. 2007;176(5):460–464. doi:10.1164/rccm.200702-337OC
   PubMed Web of Science ®Google Scholar
• Ching SM, Pang YK, Price D, et al. Detection of airflow limitation using a handheld spirometer in a primary care setting. Respirology. 2014;19(5):689–693. doi:10.1111/resp.12291
   PubMed Web of Science ®Google Scholar
• Sami R, Omidi A, Sadegh R. Validity and reliability of COPD-6 device for detecting chronic obstructive pulmonary disease in high-risk individuals. Tanaffos. 2020;19(3):201–207.
   PubMedGoogle Scholar
• Gil-Guillén V, Orozco-Beltrán D, Carratala Munuera CV, et al. FUMEPOC: early detection of chronic obstructive pulmonary disease in smokers. BMC Public Health. 2011;11(1):413. doi:10.1186/1471-2458-11-413
   PubMedGoogle Scholar
• Kjeldgaard P, Lykkegaard J, Spillemose H, Ulrik CS. Multicenter study of the COPD-6 screening device: feasible for early detection of chronic obstructive pulmonary disease in primary care? Int J Chron Obstruct Pulmon Dis. 2017;12:2323–2331. doi:10.2147/COPD.S136244
   PubMed Web of Science ®Google Scholar
• Perez-Padilla R, Wehrmeister FC, Celli BR, et al. Reliability of FEV1/FEV6 to diagnose airflow obstruction compared with FEV1/FVC: the PLATINO longitudinal study. PLoS One. 2013;8(8):e67960. doi:10.1371/journal.pone.0067960
   PubMed Web of Science ®Google Scholar